S. Estep

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection.

S. Blanchard, S. Nachman, E. Abrams, 2003, Pediatrics.

Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.

J. Lambert, S. Gurunathan, G. Tomaras, 2005, The Journal of infectious diseases.

Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s.

M. Lederman, S. Kalams, R. Moss, 2003, The Journal of infectious diseases.

Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307.

C. Flexner, R. Bosch, I. Frank, 2004, AIDS research and human retroviruses.

Short Communication: Effect of Etanercept (Enbrel) on Interleukin 6, Tumor Necrosis Factor α, and Markers of Immune Activation in HIV-Infected Subjects Receiving Interleukin 2

M. Lederman, R. Gelman, R. Walker, 2002 .

Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2.

M. Lederman, R. Gelman, R. Walker, 2002, AIDS research and human retroviruses.